Biosimilar Voices
Biosimilar Voices is a dedicated blog page to discuss issues that matter and impact biosimilar adoption. Articles highlight relevant and important topics, aiming to drive awareness and education around biosimilars. We hope in doing so it inspires you to join the Act4Biosimilars movement and help achieve the Mission to increase the global adoption of biosimilars by at least 30 percentage points in 30+ countries by 2030. If you have any content suggestions for future articles, we encourage you to share these with us at [email protected].
Education: What's needed from the patient perspective?
One of the biggest challenges to increasing biosimilar adoption is the lack of understanding and education. Laura Wingate highlights the importance of bringing the patient voice to the conversation on biosimilar education. As part of this, she recognizes the role of healthcare professionals in informing and supporting patients when starting or transitioning to a biosimilar.
Biosimilars for Rheumatoid Arthritis in the US - a year on
For people living with rheumatoid arthritis (RA) in the US, biosimilar options have been long-awaited, with biosimilars first becoming available in Europe in 2017. A year on since the first RA biosimilar launched in the US, Anna Hyde highlights the importance of this milestone, while recognizing the challenges which remain to bringing these biosimilars to patients.